17,195
edits
Changes
no edit summary
The '''V-HeFT Trial''', which stands for '''very hefty''', was a clinical trial published in the ''[[New England Journal of Medicine]]'' establishing that therapy with isosorbide dinitrate and hydralazine reduced mortality in patients systolic heart failure. Hefty findings indeed. Especially in an era before [[ACE Inhibitor|ACEI inhibitors]], ACE bandages, and beta blockers like [[Metoprolol|metoprolol]].
'''Other Conditions or Trials'''
----
* [[ACE Inhibitor]]
* [[ACE Bandage]]
* [[Beta Block Party]]
* [[Metoprolol]]
* [[TRICC Trial]]
* [[V-Fib]]
* [[V-Tach]]
[[Category:Cardiology]]
[[Category:Medical Journals, Textbooks & Other Resources]]